Michelle Norton, skin cancer clinical nurse specialist at Velindre Cancer Centre, Cardiff, shares her perspectives on the burden of an advanced melanoma diagnosis, and how this digital Health Hub helps her to support her patients with advanced melanoma from diagnosis through to treatment.
Health Professionals
Lifileucel for Unresectable or Metastatic Melanoma
On February 16, 2024, lifileucel (Amtagvi), a tumor-derived autologous T-cell immunotherapy, was granted accelerated approval for adults with unresectable or metastatic melanoma previously treated with a PD-1–blocking antibody, and if BRAF V600 mutation–positive, a BRAF inhibitor with or without a MEK inhibitor.
Adjuvant Nivolumab in Stage IIB/C Melanoma
On October 13, 2023, nivolumab was approved for adjuvant treatment of completely resected stage IIB/C melanoma in patients aged 12 years and older.
She is awarded the Sjöberg Prize for laying the foundations of a cancer vaccine
Catherine J. Wu, of the Dana-Farber Cancer Institute in Boston, USA, is a pioneer in research that may result in the development of personalised vaccines to treat cancer.